Key Highlights
- Mirador Therapeutics names Gregg Gilbert as new CFO
- Gregg brings over 25 years of biopharma equity research and investment banking experience
- Previously served as Managing Director at Bank of America Securities
- Focused on advancing Mirador’s precision therapies for immunology and inflammation
- Mirador raised over $400 million since its launch in 2024
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Gregg at this critical point in our company’s trajectory. Gregg’s impressive Wall Street experience bridges corporate and investor perspectives, and will be invaluable to guiding our next phase of growth.” — Mark C. McKenna, Chairman and CEO at Mirador Therapeutics
- “I am humbled to join this exceptionally talented and collaborative team as CFO, and look forward to making a meaningful impact as we work to deliver the next wave of precision medicines in I&I.” — Gregg Gilbert, CFO at Mirador Therapeutics
SoHC's Take
The appointment of Gregg Gilbert as CFO at Mirador Therapeutics signifies a strategic move to enhance its financial operations and investor relations as the company accelerates the development of next-generation precision therapies for immunology and inflammation. With over 25 years of experience advising biopharma companies and guiding capital strategies, Gregg’s leadership will be pivotal as Mirador transitions into its next growth phase. This appointment aligns with Mirador’s broader goal of rapidly building a diversified portfolio of transformational therapies.
Heading
Episode Details: Dental Financial Solutions Join us on this week's episode of our new Dental focused show, hosted by Jared ...
Key Highlights $11.5M Series A funding led by Construct Capital with participation from GC 1 Capital, One Way Ventures, and 2048 ...
Key Highlights Tabia Health integrates American Heart Association CarePlans into its AI-powered healthcare orchestration platform. Joins the American Heart Association Center ...
Key Highlights Heyward Donigan appointed CEO of Health Network One beginning January 1, 2025. Luis Mosquera transitions to Executive Chairman, focusing on strategic growth. Donigan ...
Key Highlights $31.5 million Series B funding led by Oak HC/FT, backed by Y Combinator, Reach Capital, and more. Programs for ...
Key Highlights Patterson Dental extends partnership with PDS Health until 2027. Agreement secures Patterson as PDS Health’s premier distributor for technology, equipment, and services. Over ...
